Suppr超能文献

包含恐嗅症的“偏头痛检查器”在偏头痛诊断中的验证。

Validation of the "My Headache Checker" that includes osmophobia in the diagnosis of migraine.

作者信息

Matsushita Masahide, Matsumoto Kaori, Kitamura Satoko, Komatsu Naoki, Seo Hiromi, Takeuchi Seisho

机构信息

Kochi General Rehabilitation Hospital Kochi Japan.

Department of General Medicine Kochi Medical School Hospital Nankoku Japan.

出版信息

J Gen Fam Med. 2020 Sep 3;22(1):24-27. doi: 10.1002/jgf2.368. eCollection 2021 Jan.

Abstract

BACKGROUND

Migraine is a common headache disorder, with a 1 year prevalence rate of 6.0 %. However, less than 10% of patients with migraine receive medication in hospital. "My Headache Checker," a brief and self-administered migraine screening tool, which includes osmophobia in addition to the ID-Migraine™ three-item subset, was developed. The objective of this study was to analyze the applicability of "My Headache Checker" in Japanese patients.

METHODS

A total of 238 patients visiting the outpatient department were enrolled in the study. The patients' chief complaint was not headache. "My Headache Checker" was administered to the patients. Subsequently, they were evaluated by a generalist for the diagnosis of headache. The clinical diagnosis of headache was determined based on the International Classification of Headache Disorders Ⅲ.

RESULTS

Twenty (8.4%) patients satisfied the criteria for the diagnosis of migraine. Sensitivity, specificity, positive predictive value, and negative predictive value of "My Headache Checker" were 0.90, 0.83, 0.69, and 0.95, respectively. Sensitivity, specificity, positive predictive value, and negative predictive value of the ID-Migraine™ were 0.90, 0.85, 0.72, and 0.95, respectively.

CONCLUSION

The majority of migraine patients are missed in busy outpatient departments. Our results suggest that "My Headache Checker" is a useful tool in diagnosing unrecognized migraine patients. However, the addition of osmophobia did not contribute to improve the screening power of the ID-Migraine™.

摘要

背景

偏头痛是一种常见的头痛疾病,1年患病率为6.0%。然而,不到10%的偏头痛患者在医院接受药物治疗。开发了一种简短的自我管理偏头痛筛查工具“My Headache Checker”,除了ID-Migraine™三项子集外,还包括畏光症状。本研究的目的是分析“My Headache Checker”在日本患者中的适用性。

方法

共有238名到门诊就诊的患者纳入本研究。患者的主要诉求不是头痛。对患者进行“My Headache Checker”测试。随后,由一名全科医生对他们进行头痛诊断评估。头痛的临床诊断根据《国际头痛疾病分类Ⅲ》确定。

结果

20名(8.4%)患者符合偏头痛诊断标准。“My Headache Checker”的敏感性、特异性、阳性预测值和阴性预测值分别为0.90、0.83、0.69和0.95。ID-Migraine™的敏感性、特异性、阳性预测值和阴性预测值分别为0.90、0.85、0.72和0.95。

结论

在繁忙的门诊中,大多数偏头痛患者被漏诊。我们的结果表明,“My Headache Checker”是诊断未被识别的偏头痛患者的有用工具。然而,增加畏光症状并没有提高ID-Migraine™的筛查能力。

相似文献

7

本文引用的文献

5
Osmophobia in primary headaches.原发性头痛中的恐嗅症
J Headache Pain. 2005 Sep;6(4):213-5. doi: 10.1007/s10194-005-0188-8.
10
Epidemiology of migraine and other types of headache in Asia.亚洲偏头痛及其他类型头痛的流行病学
Curr Neurol Neurosci Rep. 2003 Mar;3(2):104-8. doi: 10.1007/s11910-003-0060-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验